50 BCL2L10-POSITIVE CELL (BPC) QUANTIFICATION IS A PREDICTIVE FACTOR OF SURVIVAL IN AZA-TREATED HIGHER RISK MDS (HR-MDS) AND AML. (April 2015) - Cluzeau, T.; Vidal, V.; Ginet, C.; Karsenti, J.M.; Luciano, F.; Gastaud, L.; Garnier, G.; Braun, T.; Hirsch, P.; Raffoux, E.; Nloga, A.M.; Dombret, H.; et al.